Research and Markets: Drug Addiction Partnering 2009-2014 Research Report

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/bcr9nh/drug_addiction) has announced the addition of the "Drug Addiction Partnering 2009-2014" report to their offering.

Drug Addiction Partnering 2009-2014 report provides understanding and access to the drug addiction partnering deals and agreements entered into by the worlds leading healthcare companies.

- Trends in drug addiction partnering deals

- Top drugs deal addiction by value

- Deals listed by company A-Z, industry sector, stage of development, technology type

Drug Addiction Partnering 2009-2014 provides understanding and access to the drug addiction partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides an analysis of drug addiction partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug addiction technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.

This data driven report contains over 30 links to online copies of actual drug addiction deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners, where available. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

Key Topics Covered:

Executive Summary

Introduction

Trends in drug addiction partnering

Leading drug addiction deals

Dealmaking directory

Partnering resource center

Appendices

Table of figures

Companies Mentioned

Abbott

Baxter International

Celgene

Daiichi Sankyo

Eisai

Forest Laboratories

Galderma

Hospira

Johnson & Johnson

Kyowa Hakko Kirin

Lundbeck

Menarini

Novartis

Otsuka

Pfizer

Purdue

Roche

Sanofi

Takeda

Teva

Valeant

Warner Chilcott

Watson

and many more....

For more information visit http://www.researchandmarkets.com/research/bcr9nh/drug_addiction

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices, Pharmaceuticals